1. Home
  2. ATS vs LQDA Comparison

ATS vs LQDA Comparison

Compare ATS & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$28.47

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$37.64

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
LQDA
Founded
1978
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
ATS
LQDA
Price
$28.47
$37.64
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$35.00
$41.00
AVG Volume (30 Days)
158.8K
1.2M
Earning Date
02-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.81
EPS
N/A
N/A
Revenue
N/A
$158,320,000.00
Revenue This Year
$17.99
$265.61
Revenue Next Year
$3.91
$62.82
P/E Ratio
$222.92
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$20.90
$11.26
52 Week High
$33.01
$46.67

Technical Indicators

Market Signals
Indicator
ATS
LQDA
Relative Strength Index (RSI) 43.85 55.12
Support Level $26.62 $31.75
Resistance Level $30.52 $39.19
Average True Range (ATR) 1.25 1.80
MACD -0.19 0.20
Stochastic Oscillator 28.57 77.42

Price Performance

Historical Comparison
ATS
LQDA

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: